Hindustan Bio Sciences Ltd logo

Hindustan Bio Sciences Ltd (HINDBIO)

Market Open
6 Aug, 22:00
MSE MSE
6. 90
+0.2
+2.9851%
- Market Cap
- P/E Ratio
- Div Yield
64 Volume
- Eps
6.7
Previous Close
Add Transaction
Day Range
6.9 7.02
Year Range
5 9.92
Want to track HINDBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HINDBIO trading today higher at ₹6.9, an increase of 2.9851% from yesterday's close, completing a monthly decrease of -5.9946% or -₹0.44. Over the past 12 months, HINDBIO stock gained 24.774%.
HINDBIO is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0076%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

HINDBIO Chart

Hindustan Bio Sciences Ltd (HINDBIO) FAQ

What is the stock price today?

The current price is ₹6.90.

On which exchange is it traded?

Hindustan Bio Sciences Ltd is listed on MSE.

What is its stock symbol?

The ticker symbol is HINDBIO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Hindustan Bio Sciences Ltd ever had a stock split?

No, there has never been a stock split.

Hindustan Bio Sciences Ltd Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Jampana Venkata Rama Mohan Raju CEO
MSE Exchange
INE597C01021 ISIN
India Country
3 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Hindustan Bio Sciences Ltd is a pioneering entity in the pharmaceutical domain, primarily focused on the exploration, development, and distribution of biopharmaceutical products. Situated at the intersection of pharmaceutical and biotechnology sectors, this company leverages cutting-edge biotechnological advancements to moot innovative healthcare solutions aimed at addressing a spectrum of medical necessities. Recognized for adherence to superior production standards and a research-oriented approach, Hindustan Bio Sciences Ltd significantly contributes towards enhancing patient care and bolstering public health. Its recognition in the financial markets as a key player underscores its impactful role in the biopharma industry, offering critical therapies and medical treatments across varied health conditions. Through forging strategic alliances with esteemed research bodies and healthcare organizations, the company aims to broaden its product portfolio and amplify its influence in global markets.

Products and Services

Hindustan Bio Sciences Ltd's commitment to healthcare innovation is underscored by its diverse range of products and services, each designed to meet comprehensive health demands:

  • Biopharmaceutical Products - Developing and commercializing a vast array of biopharmaceuticals that cater to various therapeutic areas. This includes, but is not limited to, vaccines, monoclonal antibodies, recombinant proteins, and peptides. These products are a testament to the company’s dedication to offering advanced treatment options for diseases with significant unmet medical needs.
  • Innovative Healthcare Solutions - The company places a premium on pioneering healthcare solutions that leverage biotechnological advancements. This involves creating therapies that yield significant clinical benefits, ultimately improving the quality of life for patients across numerous conditions.
  • Research and Development - At the core of Hindustan Bio Sciences Ltd’s operations is its unwavering commitment to R&D. This emphasis ensures the constant flow of innovative products into the market, addressing new and existing health challenges with science-backed approaches.
  • Strategic Partnerships - Recognizing the importance of collaboration, the company actively engages in strategic partnerships with research institutions and healthcare organizations. These collaborations are vital in expanding its reach, enhancing its product lineup, and reinforcing its standing in the biotechnology and pharmaceutical sectors.

Contact Information

Address: H.No: 8-2-269/S, Plot No. 31
Phone: 91 40 2355 5181